Yüklüyor......
PGRMC1: a new biomarker for the estrogen receptor in breast cancer
Estrogen receptor (ER) status is a critical biomarker in breast cancer, in large part because the ER is the target of tamoxifen and similar drugs. In the previous issue of Breast Cancer Research, Neubauer and colleagues used a proteomic approach to identify proteins that are differentially regulated...
Kaydedildi:
| Yazar: | |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
BioMed Central
2008
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2656908/ https://ncbi.nlm.nih.gov/pubmed/19090968 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/bcr2191 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|